Anavex: Looking At Different Statistical Approaches Before EMA Opinion
Anavex Life Sciences Corp.'s stock rises 50% as EMA reviews Alzheimer's drug blarcamesine. Click for my updated look at AVXL stock and why I have upgraded it.
Regis outlines growth strategy with Alline acquisition and loyalty program expansion
CEO Matthew Doctor emphasized the strategic significance of acquiring the Alline Salon Group, describing it as a milestone in stabilizing and growing the company. The $22 million acquisition includes ...